Analytical Data
-
基因名
FAM135B
- Application
-
别名
C8ORFK32
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9DAI6
-
表达区间
Leu1068~Lys1403
-
分子量
42kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM135B, a member of the FAM135 gene family, has garnered attention in recent years due to its potential roles in various cellular processes and diseases. Originally identified through genomic studies, FAM135B is believed to participate in pathways that regulate cell proliferation, apoptosis, and immune response. Research indicates that alterations in the expression of FAM135B may be implicated in several types of cancer, making it a candidate for exploration in tumor biology and therapeutic interventions. As a recombinant protein, FAM135B can be effectively expressed and purified for in vitro studies, allowing researchers to delve deeper into its biological functions and interaction networks. Understanding the molecular mechanisms governed by FAM135B is crucial for elucidating its role in health and disease. Additionally, studying the protein’s structure and function may unveil new insights into its potential as a biomarker or therapeutic target, paving the way for novel strategies in cancer treatment and other pathologies associated with dysregulation of its expression. In summary, the study of FAM135B recombinant protein is poised to contribute significantly to our understanding of its biological relevance and therapeutic potential, underscoring the importance of translating basic research into clinical applications.












